J. Hussner

发表

PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism

H. E. Meyer zu Schwabedissen, I. Seibert, Fabiola Porta, 2019, Materials.

Endogenous Coproporphyrin I and III Are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

K. Brouwer, J. Beaudoin, H. E. Meyer zu Schwabedissen, 2020, Journal of pharmaceutical sciences.

Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells

H. E. Meyer zu Schwabedissen, U. Zimmermann, J. Hussner, 2016, OncoTargets and therapy.

The scaffold protein PDZK1 modulates expression and function of the organic anion transporting polypeptide 2B1

H. E. Meyer zu Schwabedissen, M. Grube, P. Hagen, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers

S. Krähenbühl, M. Karlsson, H. E. Meyer zu Schwabedissen, 2019, British journal of clinical pharmacology.

Genetic variants of SLCO1B7 are of relevance for the transport function of OATP1B3-1B7.

H. M. Z. Schwabedissen, W. Siegmund, I. Seibert, 2020, Pharmacological research.

OATP1B3-1B7 a novel Organic Anion Transporting Polypeptide is modulated by FXR ligands and transports bile acids.

H. E. Meyer zu Schwabedissen, V. Malagnino, J. Hussner, 2019, American journal of physiology. Gastrointestinal and liver physiology.

In vitro study of dual drug-eluting stents with locally focused sirolimus and atorvastatin release

H. Kroemer, K. Schmitz, N. Grabow, 2013, Journal of Materials Science: Materials in Medicine.

Transcriptional regulation of urate transportosome member SLC2A9 by nuclear receptor HNF4α.

H. Kroemer, H. E. Meyer zu Schwabedissen, C. Rimmbach, 2014, American journal of physiology. Renal physiology.

Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells

U. Völker, H. Kroemer, J. Niessen, 2012, Molecular Pharmacology.

Pimecrolimus increases the expression of interferon-inducible genes that modulate human coronary artery cells proliferation.

I. Seibert, H. M. Z. zu Schwabedissen, J. Hussner, 2016, European journal of pharmacology.

Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices.

H. Kroemer, K. Schmitz, H. E. Meyer zu Schwabedissen, 2014, Molecular pharmaceutics.

LST‐3TM12 is a member of the OATP1B family and a functional transporter

H. E. Meyer zu Schwabedissen, I. Seibert, V. Malagnino, 2018, Biochemical pharmacology.

PDZ domain containing protein 1 (PDZK1), a modulator of membrane proteins, is regulated by the nuclear receptor THRβ

H. M. Z. Schwabedissen, U. Zimmermann, J. Hussner, 2017, Molecular and Cellular Endocrinology.

Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide

H. E. Meyer zu Schwabedissen, T. Einfalt, J. Huwyler, 2019, eLife.

Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.

A. Schmidt, Timo Glatter, H. E. Meyer zu Schwabedissen, 2016, Molecular pharmaceutics.

Regulation of PDZ domain-containing 1 (PDZK1) expression by hepatocyte nuclear factor-1α (HNF1α) in human kidney.

H. E. Meyer zu Schwabedissen, I. Seibert, U. Zimmermann, 2017, American journal of physiology. Renal physiology.

Differences in transport function of the human and rat orthologue of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1).

H. E. Meyer zu Schwabedissen, A. Fuchs, I. Seibert, 2021, Drug metabolism and pharmacokinetics.

Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery.

H. E. Meyer zu Schwabedissen, J. Hussner, D. Gliesche, 2015, Vascular pharmacology.

Functional assessment of genetic variants located in the promoter of SHP1 (NR0B2).

H. Völzke, H. E. Meyer zu Schwabedissen, J. Hussner, 2017, Pharmacogenetics and genomics.

Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.

A. Schmidt, Timo Glatter, J. Huwyler, 2016, Molecular pharmaceutics.

Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices.

K. Schmitz, K. Sternberg, J. Hussner, 2014, Molecular pharmaceutics.